Serif Biomedicines has emerged from stealth mode to continue developing “modified DNA,” a new class of therapeutics designed ...

Cancer tumorigenesis is fundamentally driven by the profound dysregulation of gene regulatory networks (GRNs) and complex epigenetic alterations. With the ...

Immunological microcosms and genetic changes are central to understanding the mechanisms that drive disease progression and response to treatments. Research ...